Trial intelligence / Profile preview

Injectable Sanhuafen preparation for acute cerebral infarction

CTR20150211Phase 2Active

Sponsor
Tsinghua Yuanxing Pharmaceutical
Start
May 2015
Countries
1
01

Overview

A Phase 2 trial of Sanhua for injection in brain infarction, sponsored by Tsinghua Yuanxing Pharmaceutical. Started May 2015; status: active.

02

Drugs

Sanhua for injection
03

Conditions

brain infarction

Beyond the preview

Go deeper on CTR20150211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call